PL367619A1 - Zastosowanie surowic do selekcji bibliotek cDNA wcelu identyfikacji specyficznych antygenów nowotworowych i wykorzystanie tych antygenów w diagnostycznych technikach obrazowania - Google Patents
Zastosowanie surowic do selekcji bibliotek cDNA wcelu identyfikacji specyficznych antygenów nowotworowych i wykorzystanie tych antygenów w diagnostycznych technikach obrazowaniaInfo
- Publication number
- PL367619A1 PL367619A1 PL02367619A PL36761902A PL367619A1 PL 367619 A1 PL367619 A1 PL 367619A1 PL 02367619 A PL02367619 A PL 02367619A PL 36761902 A PL36761902 A PL 36761902A PL 367619 A1 PL367619 A1 PL 367619A1
- Authority
- PL
- Poland
- Prior art keywords
- antigens
- sera
- selection
- imaging techniques
- cdna libraries
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2541/00—Reactions characterised by directed evolution
- C12Q2541/10—Reactions characterised by directed evolution the purpose being the selection or design of target specific nucleic acid binding sequences
- C12Q2541/101—Selex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2001/000405 WO2003010198A1 (en) | 2001-07-26 | 2001-07-26 | Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques |
| PCT/IT2002/000491 WO2003010199A2 (en) | 2001-07-26 | 2002-07-25 | Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367619A1 true PL367619A1 (pl) | 2005-03-07 |
Family
ID=11133704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02367619A PL367619A1 (pl) | 2001-07-26 | 2002-07-25 | Zastosowanie surowic do selekcji bibliotek cDNA wcelu identyfikacji specyficznych antygenów nowotworowych i wykorzystanie tych antygenów w diagnostycznych technikach obrazowania |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050084857A1 (pl) |
| EP (1) | EP1409537A2 (pl) |
| JP (1) | JP2005508616A (pl) |
| KR (1) | KR20040035687A (pl) |
| CA (1) | CA2454784A1 (pl) |
| HU (1) | HUP0400663A2 (pl) |
| MX (1) | MXPA04000648A (pl) |
| PL (1) | PL367619A1 (pl) |
| WO (2) | WO2003010198A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8795332B2 (en) | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
| EP1551178A1 (en) | 2003-12-18 | 2005-07-06 | Koninklijke Philips Electronics N.V. | Supplementary visual display system |
| US7858323B2 (en) * | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
| MX2009008248A (es) | 2007-02-07 | 2009-08-12 | Sigma Tau Ind Farmaceuti | Antigenos recombinantes de citomegalovirus humano. |
| US20080255612A1 (en) | 2007-04-13 | 2008-10-16 | Angiotech Pharmaceuticals, Inc. | Self-retaining systems for surgical procedures |
| US8216273B1 (en) | 2008-02-25 | 2012-07-10 | Ethicon, Inc. | Self-retainers with supporting structures on a suture |
| EP2108656A1 (en) | 2008-03-19 | 2009-10-14 | Beninati, Concetta | Antigenic protein fragments of streptococcus pneumoniae |
| WO2009135295A1 (en) | 2008-05-09 | 2009-11-12 | University Of Saskatchewan | Phage lambda display constructs |
| EP3450979A3 (en) | 2010-03-17 | 2019-04-24 | The Regents of The University of Michigan | Using phage epitopes to profile the immune response |
| EP2661278B1 (en) * | 2011-01-04 | 2019-06-19 | SillaJen Biotherapeutics, Inc. | Tumor specific complement dependent cytotoxicity (cdc) antibodies generated by administration of oncolytic vaccinia virus, for use in the treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU778776B2 (en) * | 1999-04-14 | 2004-12-23 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | High sensitivity phage display biomolecule detection |
| CN1307036A (zh) * | 2000-01-26 | 2001-08-08 | 上海博道基因技术有限公司 | 一种新的多肽——人分裂复合物69和编码这种多肽的多核苷酸 |
| FR2804690B1 (fr) * | 2000-02-07 | 2004-11-05 | Centre Nat Rech Scient | Nouvelles famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AU2001266787A1 (en) * | 2000-06-07 | 2002-01-08 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
-
2001
- 2001-07-26 WO PCT/IT2001/000405 patent/WO2003010198A1/en not_active Ceased
-
2002
- 2002-07-25 WO PCT/IT2002/000491 patent/WO2003010199A2/en not_active Ceased
- 2002-07-25 KR KR10-2004-7000953A patent/KR20040035687A/ko not_active Withdrawn
- 2002-07-25 JP JP2003515558A patent/JP2005508616A/ja active Pending
- 2002-07-25 PL PL02367619A patent/PL367619A1/pl unknown
- 2002-07-25 EP EP02790222A patent/EP1409537A2/en not_active Withdrawn
- 2002-07-25 HU HU0400663A patent/HUP0400663A2/hu unknown
- 2002-07-25 CA CA002454784A patent/CA2454784A1/en not_active Abandoned
- 2002-07-25 MX MXPA04000648A patent/MXPA04000648A/es not_active Application Discontinuation
- 2002-07-25 US US10/484,917 patent/US20050084857A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2454784A1 (en) | 2003-02-06 |
| HUP0400663A2 (hu) | 2005-01-28 |
| WO2003010199A2 (en) | 2003-02-06 |
| EP1409537A2 (en) | 2004-04-21 |
| JP2005508616A (ja) | 2005-04-07 |
| WO2003010199A3 (en) | 2003-10-02 |
| WO2003010198A1 (en) | 2003-02-06 |
| MXPA04000648A (es) | 2004-03-19 |
| US20050084857A1 (en) | 2005-04-21 |
| KR20040035687A (ko) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2019018I1 (el) | Μορια αντισωματων εξειδικευμενα για τον ανθρωπινο παραγοντα νεκρωσης των ογκων αλφα, και χρηση αυτων | |
| DE50109149D1 (de) | Computertomograph zur Ermittlung des Impulsübertrags-Spektrums in einem Untersuchungsbereich | |
| DK1411064T3 (da) | Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer | |
| SI1957539T1 (sl) | Humana monoklonska protitelesa proti protein tirozin kinazi 7 (PTK7) in njihova uporaba | |
| FR16C1012I2 (fr) | Utilisation therapeutique d'anticorps anti-cs1 | |
| IL200404A (en) | Conjugates of antibodies that bind 191p4d12(b)proteins and uses thereof for treating cancer | |
| DE60113409D1 (de) | Kombinierte impedanzbildgebung und mammographie | |
| EP1515982A4 (en) | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER | |
| NO20014769L (no) | Preparat for behandling og diagnostikk av brystcancer og fremgangsmater for anvendelse derav | |
| EP1456910A4 (en) | INTERRUPTING THERAPEUTIC PROBE | |
| EP1427494A4 (en) | PROCEDURE VERIFICATION | |
| DE60236010D1 (de) | Kalibrierung der gewebedichte in der computertomographie | |
| EP1589933A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| DE69936333D1 (de) | Photo Ultraschall Streuwellen Tumorfühler | |
| DE60138118D1 (de) | Spiralabtastrekonstruktion des herzens für tomograph mit zweidimensionaler detektoranordung | |
| EP1553912A4 (en) | COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT | |
| EP1516049A4 (en) | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER | |
| EP1520032A4 (en) | THERAPEUTICS AND DIAGNOSIS FOR LUNG CANCER | |
| EP1680666A4 (en) | DETECTION OF HUMAN ANTITHERAPEUTIC ANTIBODIES | |
| PL367619A1 (pl) | Zastosowanie surowic do selekcji bibliotek cDNA wcelu identyfikacji specyficznych antygenów nowotworowych i wykorzystanie tych antygenów w diagnostycznych technikach obrazowania | |
| ITMI20011619A0 (it) | Procedimento per la preparazione di materiali in fibra acrilica idrorepellenti | |
| EP1552019A4 (en) | CANCER DIAGNOSTICS AND PROGNOSIS | |
| IS6381A (is) | Nýjung við notkun mótefna í bóluefni | |
| PL371202A1 (pl) | Antyidiotypowe cząsteczki przeciwciała przeciwko-CEA oraz ich zastosowanie jako szczepionki przeciwnowotworowej | |
| HUP0400661A3 (en) | Identification of specific tumor antigens by means of the selection os cdna libraries with sera and the use of said antigena in the treatment of tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |